Overview

Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis

Status:
RECRUITING
Trial end date:
2025-12-30
Target enrollment:
Participant gender:
Summary
A multicenter, randomized, double-blind, vehicle controlled phase II clinical study
Phase:
PHASE2
Details
Lead Sponsor:
Jiangsu vcare pharmaceutical technology co., LTD